BridgeBio Pharma, Inc. Common Stock
€57.12
EUR
Last updated on --.
24h volume2.72M
24h highest60.0796 EUR
24h lowest56.3730 EUR
24h Price movement-1.93%
BBIO recent prices
24 Hours
-1.93%-€1.127
30 days
-5.46%-€3.275
60 days
-4.98%-€2.974
90 days
-0.87%-€0.49622
Key data
Previous close58.2478 EUR
Market cap11.49B EUR
Volume2.72M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.1648 EUR
Net income (FY)-627.70M EUR
Revenue (FY)498.76M EUR
Last report date7 May 2026
About BridgeBio Pharma, Inc. Common Stock
HeadquartersPALO ALTO
Employees (FY)839.00
Revenue per employee (FY)594.47K EUR
Net income per employee (FY)-748.15K EUR
Listed onNasdaq
BBIO conversion tables
 |  |
|---|---|
| 0.5 BBIO | 28.56 EUR |
| 1 BBIO | 57.12 EUR |
| 5 BBIO | 285.6 EUR |
| 10 BBIO | 571.21 EUR |
| |
|---|---|
| 0.5 EUR | 0.0087533 BBIO |
| 1 EUR | 0.017507 BBIO |
| 5 EUR | 0.087533 BBIO |
| 10 EUR | 0.17507 BBIO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BBIO is trading at €57.12, -1.93% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BBIO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BBIO is currently trading at €57.12, -1.93% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BBIO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BBIO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BBIO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BBIO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
BridgeBio Pharma, Inc. Common Stock's market cap is currently 11.49B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.72M
24h highest60.0796 EUR
24h lowest56.3730 EUR
24h Price movement-1.93%
Start trade with BBIO Perpetual
Sign up to trade